Venock
1 known investors
Find your way into Venock
Sign up to see every warm intro you have to Venock
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Venock team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Venock is developing a percutaneous handheld vascular closure device that automatically seals large-bore punctures in the femoral vein within 1-2 minutes following interventional procedures. It targets interventional cardiologists, hospitals, and cathlabs performing trans-venous therapies such as structural heart interventions in the USA and Europe.
Investors · 1
Frequently asked questions
- What does Venock do?
- Venock is developing a percutaneous handheld vascular closure device that automatically seals large-bore punctures in the femoral vein within 1-2 minutes following interventional procedures. It targets interventional cardiologists, hospitals, and cathlabs performing trans-venous therapies such as structural heart interventions in the USA and Europe.
- Who are Venock's investors?
- Venock's investors include New York Angels.